Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 49: 805-808, 2003; 10.1373/49.5.805
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Tables
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujita, K.
Right arrow Articles by Katsuyama, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujita, K.
Right arrow Articles by Katsuyama, T.
Related Collections
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2003;49:805-808.)
© 2003 American Association for Clinical Chemistry, Inc.

Technical Briefs

Identification and Properties of Glycated Monoclonal IgA That Affect the Fructosamine Assay

Kiyotaka Fujita1,a, Linda K. Curtiss1, Ikunosuke Sakurabayashi2, Fumiko Kameko3, Nobuo Okumura3, Fumiko Terasawa3, Minoru Tozuka4 and Tsutomu Katsuyama4

1 Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Rd., La Jolla, CA 92037;

2 Department of Clinical Laboratories, Omiya Medical Center, Jichi Medical School, Amanuma, Saitama 330-8503, Japan;

3 Department of Biomedical Laboratory Sciences, School of Health Sciences, Shinshu University, Asahi, Matsumoto, Nagano 390-8621, Japan;

4 Department of Laboratory Medicine, Shinshu University School of Medicine, Asahi, Matsumoto, Nagano 390-8621, Japan;

aauthor for correspondence: fax 858-784-9144, e-mail kyfujit@aol.com

The first 300 words of the full text of this article appear below.

Serum fructosamine is used to monitor short-term (1–3 weeks) average glycemia (1)(2), but controversy remains whether it is influenced by the serum concentrations of albumin (3)(4), IgA (5)(6), or monoclonal IgA (7)(8). We recently demonstrated glycation of monoclonal IgA and the presence of IgA-albumin complexes (9), but the relationship between the glycation of monoclonal IgA and the IgA-albumin complexes was not clear.

In this study, we measured immunoglobulin-albumin complexes, serum fructosamine, and the glycation of immunoglobulin in patients with monoclonal proteinemia and in patients with polyclonal hyper-IgA.

We obtained serum samples from 40 patients with M-proteinemia with no history of diabetes and whose plasma glucose concentrations were <1.1 g/L. The M-protein was IgG in 17 of the patients [mean (SD), 29.2 (21.0) g/L], IgA in 13 [18.5 (16.4) g/L], and IgM in 10 [16.8 (11.3) g/L]. We also analyzed sera from 15 nondiabetic patients with hepatitis who had polyclonal hyper-IgA [5.1 (1.1) g/L] as controls.

Serum fructosamine was measured at 37 °C in an automated analyzer (JCA-RX 10 Clinalyzer; Japan Electron Optics Laboratory) with reagents from Roche Diagnostics Corporation.

Serum protein electrophoresis was performed on agarose gels. Immunoelectrophoresis was based on the method of Scheidegger (10). Fructosamine was detected on agarose gels by incubating the gel for 30 min at 37 °C with a 2x concentration of a fructosamine reagent.

IgA was isolated from serum with use of a jacalin-agarose (Funakoshi Corporation) column (11) and 0.8 mol/L galactose to elute the IgA. The IgA fraction was dialyzed against 0.2 mol/L Tris-HCl buffer (pH 8.0), concentrated by ultrafiltration, loaded on a DEAE-Sephacel (Amersham Pharmacia Biotech) ion-exchange column, and eluted with a linear gradient of 0–0.5 mol/L NaCl in . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.